The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent ...

Shrugging off an earlier phase 3 disappointment, Travere’s Filspari has become the first FDA-approved treatment for rare kidney disease focal segmental glomerulosclerosis (FSGS). The company's already ...

Hogan Lovells partner Alice Valder Curran returned to join pharmaphorum editor-in-chief Jonah Comstock to elucidate some of ...

A woman from the Wirral in the UK has become the first patient in the world to receive an experimental cancer vaccine ...

According to a letter (PDF) signed by US Senators Elizabeth Warren (D-Mass), Angela Alsobrooks (D-Md), Richard Blumenthal ...

The once-daily, oral TEC/JAK3 inhibitor has shown efficacy in active and stable nonsegmental vitiligo (NSV) – the most common form of the disease – in which the most common form of vitiligo, ...

UK biotech Antiverse has raised $9.3 million to accelerate its drug discovery programmes, based on an AI-powered platform for designing antibody-based therapeutics. Cardiff, Wales-based Antiverse's ...

FDA advisors have voted that Capricor Therapeutics has not provided strong evidence of efficacy for its cell therapy for ...

Anti-OX40L antibody amlitelimab was discarded as a treatment for atopic dermatitis last week, and today – during its ...

Cytokinetics is one of the first drugmakers to benefit from the UK's dual regulatory and reimbursement appraisals, getting a ...

Recordati has received an unsolicited takeover offer from private equity group CVC Capital Partners that, if completed, would delist the pharma group from the Italian stock exchange. The €52-per-share ...

For most of biopharma's history, organisations treated this kind of reasoning as something that would transfer on its own ...